Recursion Competitors

Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com. Stay Alert: Avoid Recruitment Scams Across industries, cybercriminals are posing as company recruiters using fake job postings and employment offers. Please stay vigilant: - Never provide personal/financial information or payment to anyone claiming to offer a job opportunity - Always verify job postings through official company websites or direct contacts - Be cautious of unusual communication methods or overly quick offers

Tata 1mg is India’s #1 digital health platform. Launched in 2015 (originally as 1mg), the platform is trusted by millions of Indians for making healthcare accessible, understandable, and affordable. With over 200 million unique visitors annually, it ranks among the world’s largest healthcare content platforms. It also serves around 6 million people annually for their healthcare transaction needs. Tata 1mg offers integrated healthcare services including ePharmacy, Diagnostics and eConsultations, delivered via a digital platform, institutional partners as well as with a growing network of retail stores across India. It is a clear market leader across its key business segments and one of the fastest growing D2C Consumer branded supplements players in India. Tata 1mg also has one of the largest structured databases of healthcare data in the country and is one of India’s leading players in the use of AI models in healthcare in India. Tata 1mg leverages its omnichannel network to deliver medicines pan-India in over 20K pincodes. The company also operates 19 state-of-the-art NABL and CAP accredited diagnostic labs and its at-home diagnostics collection is powered by a dedicated fleet of over 1200 trained phlebotomists, offering on-time and reliable lab tests in more than 70 cities across India. It is now using the same world-class supply chain to power healthcare for corporates and insurance providers across the country offering services like Occupational Health Centers, Pre policy medical checks, Annual health checks, etc. Tata 1mg has recently achieved profitability for all its core business lines, and is actively investing to grow its retail expansion given the tremendous growth opportunities in the space. With a focus on innovation and accessibility, Tata 1mg is redefining healthcare in India, ensuring that quality care is always within reach, wherever you are.

Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.